These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38873256)

  • 21. Cytology versus HPV testing for cervical cancer screening in the general population.
    Koliopoulos G; Nyaga VN; Santesso N; Bryant A; Martin-Hirsch PP; Mustafa RA; Schünemann H; Paraskevaidis E; Arbyn M
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008587. PubMed ID: 28796882
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].
    Della Palma P; Moresco L; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 3):e1-43. PubMed ID: 23139174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits and potential harms of human papillomavirus (HPV)-based cervical cancer screening: A real-world comparison of HPV testing versus cytology.
    Thomsen LT; Kjaer SK; Munk C; Ørnskov D; Waldstrøm M
    Acta Obstet Gynecol Scand; 2021 Mar; 100(3):394-402. PubMed ID: 33566361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Olthof EMG; Aitken CA; Siebers AG; van Kemenade FJ; de Kok IMCM
    Public Health; 2024 Feb; 227():42-48. PubMed ID: 38103276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anal dysplasia screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(4):1-43. PubMed ID: 23074504
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV status, age at cervical Cancer screening and cervical cytology outcomes in an opportunistic screening setting in Nigeria: a 10-year Cross sectional data analysis.
    Musa J; Achenbach CJ; Evans CT; Jordan N; Daru PH; Silas O; Sagay AS; Anorlu R; Mehta SD; Wehbe F; Simon MA; Adewole IF; Hou L; Murphy RL
    Infect Agent Cancer; 2019; 14():43. PubMed ID: 31798680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Real-world research on cervical cancer screening program and effect evaluation for Chinese population].
    Zhao YQ; Dai Y; Dang L; Kong LH; Zhang Y; Feng RM; Qiao YL; Lang JH
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):764-771. PubMed ID: 30392341
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis.
    Sroczynski G; Schnell-Inderst P; Mühlberger N; Lang K; Aidelsburger P; Wasem J; Mittendorf T; Engel J; Hillemanns P; Petry KU; Krämer A; Siebert U
    Eur J Cancer; 2011 Jul; 47(11):1633-46. PubMed ID: 21482103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study.
    Thomsen LT; Kjær SK; Munk C; Frederiksen K; Ørnskov D; Waldstrøm M
    Clin Epidemiol; 2020; 12():203-213. PubMed ID: 32110112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
    Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
    BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.
    Stuardo V; Agustí C; Godinez JM; Montoliu A; Torné A; Tarrats A; Alcalde C; Martín D; Fernández-Montoli E; Vanrell C; Solé J; Canet Y; Marqueta JM; Mohamed J; Cuenca I; Lonca M; Sirera G; Ferrer E; Domingo P; Lloveras B; Miro JM; De Sanjosé S; Casabona J
    PLoS One; 2012; 7(10):e47755. PubMed ID: 23118894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Participation in the nationwide cervical cancer screening programme in Denmark during the COVID-19 pandemic: An observational study.
    Olesen TB; Jensen H; Møller H; Jensen JW; Waldstrøm M; Andersen B
    Elife; 2023 Jan; 12():. PubMed ID: 36661213
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Screening for Cervical Cancer in Primary Care: A Decision Analysis for the US Preventive Services Task Force.
    Kim JJ; Burger EA; Regan C; Sy S
    JAMA; 2018 Aug; 320(7):706-714. PubMed ID: 30140882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytology and human papillomavirus testing 6 to 12 months after ASCUS or LSIL cytology in organized screening to predict high-grade cervical neoplasia between screening rounds.
    Tropé A; Sjøborg KD; Nygård M; Røysland K; Campbell S; Alfsen GC; Jonassen CM
    J Clin Microbiol; 2012 Jun; 50(6):1927-35. PubMed ID: 22518869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.
    Schneider A; Hoyer H; Lotz B; Leistritza S; Kühne-Heid R; Nindl I; Müller B; Haerting J; Dürst M
    Int J Cancer; 2000 Nov; 89(6):529-34. PubMed ID: 11102899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Coverage of cervical cancer screening in Catalonia, Spain (2008-2011)].
    Rodríguez-Salés V; Roura E; Ibáñez R; Peris M; Bosch FX; Coma E E; Silvia de Sanjosé
    Gac Sanit; 2014; 28(1):7-13. PubMed ID: 23916983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytology-based screening for anal intraepithelial neoplasia in women with a history of cervical intraepithelial neoplasia or cancer.
    Wohlmuth C; Ghorab Z; Shier M; Tinmouth J; Salit IE; Covens A; Zhang L; Vicus D
    Cancer Cytopathol; 2021 Feb; 129(2):140-147. PubMed ID: 33002327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.
    Leinonen M; Nieminen P; Kotaniemi-Talonen L; Malila N; Tarkkanen J; Laurila P; Anttila A
    J Natl Cancer Inst; 2009 Dec; 101(23):1612-23. PubMed ID: 19903804
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.